L
290650
vs
K
KOSPI 200
Over the past 12 months, L&C Bio Co Ltd has significantly outperformed KOSPI 200, delivering a return of +270% compared to the KOSPI 200's +108% growth.
Stocks Performance
290650 vs KOSPI 200
Performance Gap
290650 vs KOSPI 200
Performance By Year
290650 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
L&C Bio Co Ltd
Glance View
L&C BIO Co., Ltd. develops soft tissue, allografts, and medical devices. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-11-01. The firm mainly manufactures and sells human tissue transplant materials used for tissue repair and filler. The firm also produces and sells human tissue-based medical devices and Cosmeceuticals. Its products are used in vascular surgeries, plastic surgeries, general surgeries and others.